In conversation with Verily’s medical science chief Andrew Trister on the company’s narrowed focus

In January 2023, Verily Life Sciences began to pull back from the many different areas of the healthcare sector in which it once played to better tailor its bets on becoming a more profitable company.

Once known for tackling everything from smart contact lenses and wearable sensors to surgical…
Click here to view original post

Click Here to Publish/Feature Your Company or Product News with Biotech Networks